Literature DB >> 22319042

Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients.

Ling Zhang1, Wen-Jun Wei, Qing-Hai Ji, Yong-Xue Zhu, Zhuo-Ying Wang, Yu Wang, Cai-Ping Huang, Qiang Shen, Duan-Shu Li, Yi Wu.   

Abstract

CONTEXT: The surgical management of papillary thyroid microcarcinoma (PTMC), especially regarding the necessity of central lymph node dissection, remains controversial.
OBJECTIVE: The objective of the study was to describe the clinicopathological features of PTMC and to identify the risk factors for central lymph node metastasis (CLNM) that can guide surgical strategies for patients with PTMC.
DESIGN: In this retrospective cross-sectional study, risk factors and outcome variables were assessed at the time of surgery for the primary tumor.
SETTING: The study was conducted at a university-based tertiary care cancer hospital. PATIENTS: Data from the medical records of 1066 consecutive patients diagnosed with PTMC over a 5-yr period were analyzed.
RESULTS: Our multivariate logistic regression analysis found male gender, younger age (≤45 yr of age), multifocal lesions, extrathyroidal extension, and larger size of the primary tumor (>6 mm) to be associated with CLNM; multifocal lesions were associated with the highest risk (odds ratio 4.476, 95% confidence interval 2.975-6.735). Extrathyroidal extension, multifocal lesions, and CLNM were associated with lateral neck lymph node metastasis (LLNM). In patients with a solitary primary tumor, tumor location in the upper third of the thyroid lobe was associated with a lower risk of CLNM and a higher risk of LLNM.
CONCLUSIONS: Prophylactic central lymph node dissection need be considered in PTMC patients presenting with risk factors. In PTMC patients with a solitary primary tumor, tumor location can assist in the evaluation of LLNM. We recommend multicenter research and long-term follow-up to better understand the risk factors and surgical management of PTMC.

Entities:  

Mesh:

Year:  2012        PMID: 22319042     DOI: 10.1210/jc.2011-1546

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  114 in total

1.  [Lateral skip metastases in papillary thyroid carcinoma].

Authors:  H Dralle
Journal:  Chirurg       Date:  2012-07       Impact factor: 0.955

2.  The impact of coexistent Hashimoto's thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma.

Authors:  Ning Qu; Ling Zhang; Dao-Zhe Lin; Qing-Hai Ji; Yong-Xue Zhu; Yu Wang
Journal:  Tumour Biol       Date:  2015-12-21

3.  Prediction of central lymph node metastasis in 392 patients with cervical lymph node-negative papillary thyroid carcinoma in Eastern China.

Authors:  Yingying Xiang; Kuailu Lin; Siyang Dong; L I Qiao; Qiuxiang He; Xiaohua Zhang
Journal:  Oncol Lett       Date:  2015-07-29       Impact factor: 2.967

4.  Should patients with papillary microcarcinoma undergo radioiodine ablation?

Authors:  Leonard Wartofsky
Journal:  Endocrine       Date:  2013-07-02       Impact factor: 3.633

5.  Clinical characteristics of papillary thyroid microcarcinoma less than or equal to 5 mm on ultrasonography.

Authors:  Hyoung Shin Lee; Hyo Sang Park; Sung Won Kim; Gwan Choi; Hun-Su Park; Jong-Chul Hong; Sung-Geun Lee; Seon Mi Baek; Kang Dae Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-20       Impact factor: 2.503

Review 6.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

7.  Does preoperative neutrophil lymphocyte ratio predict risk of recurrence and occult central nodal metastasis in papillary thyroid carcinoma?

Authors:  Brian Hung-Hin Lang; Cathy Po-Ching Ng; Kin Bun Au; Kai Pun Wong; Kandy K C Wong; Koon Yat Wan
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

Review 8.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

Review 9.  The Effectiveness of Radioactive Iodine Remnant Ablation for Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-analysis.

Authors:  Guangfu Hu; Wei Zhu; Weige Yang; Hong Wang; Lei Shen; Hongwei Zhang
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

10.  Adequacy of pathology reports of specimens from patients with differentiated thyroid cancer.

Authors:  Ma Luisa Isidro; Gloria Lugo; Olga Fidalgo; Sara García-Arias
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.